Akur8 vs hyperexponential (2026)
The structural difference is who builds the model, and everything else follows from it. At Akur8 the machine builds it: Transparent Machine Learning automates feature engineering, variable selection and geospatial smoothing to construct risk models the company states are produced up to ten times faster than manual methods, while keeping every coefficient legible to the actuary. At hyperexponential the carrier's own actuaries build it, authoring, deploying and versioning pricing models in a Python engine, with no model learning the price. That produces the sharpest difference between them. Akur8's validation is structural rather than documentary: every model it produces passes two external checks the vendor does not control, a certified actuary signing under professional obligation and a regulator receiving it as a rate filing with power to reject. hyperexponential documents its integrations in detail, with named partnerships, the carrier's policy administration system left as the system of record, and a portability commitment giving customers structured access to all data, configuration and code at any time, a promise this market rarely puts in writing. The two companies also hold a partnership covering specialty and commercial pricing, so this is not a straight contest.
- You want the model built rather than the tooling to build it. Automated feature engineering, variable selection and geospatial smoothing produce risk models up to ten times faster than manual methods with every variable contribution visible, and gradient boosted models sit alongside generalized linear and additive families without surrendering interpretability.
- Regulatory filing is the destination. The platform is built for the rate filing path with a rate repository, a deployment engine carrying approved rates into production, and Akur8 Discover reading unstructured filings so an insurer can benchmark rate movements across states, perils and lines and anticipate objections before filing.
- Constraint has to be a product feature, not a report. Published work addresses pricing where risk model insight cannot be reflected in price because regulators forbid it, naming health and mandatory lines as ethically sensitive, so the platform is built to exclude and cap variables and evidence that exclusion to a supervisor.
- Reserving sits in the same contract. The Arius product acquired from Milliman replaces spreadsheet based reserve analysis and arrived with 150 insurance and consulting clients, more than a third of them top tier carriers in the United States and Canada.
- Your actuaries own the models and intend to keep owning them. Pricing runs on a Python engine in which the carrier's own actuaries author, deploy and version the models, so nothing is inherited as a black box and the intellectual property stays in house.
- Specialty and complex commercial risk is the book. More than 45 billion dollars of gross written premium is contracted through the platform annually across Aviva, Markel, Sompo, Convex, Conduit Re, HDI and the specialty managing general agent Novacore.
- You want an exit path in writing. Customers retain structured access to all data, configuration and code at any time, stated as a commitment to transparency and operational continuity, alongside named integrations with Send, Cytora and Supercede and an explicit statement that the policy administration system remains the system of record.
- Change control is the audit requirement. Every decision, every rule change and every model update is captured end to end and framed as a path for regulatory review, so a model risk function can reconstruct how any given price was reached and what changed since the last version.
This comparison is published by AI FinTech Index, an independent research platform that publishes independent ratings of AI vendors for financial services. Akur8 and hyperexponential are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI FinTech Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Akur8 | hyperexponential | |
|---|---|---|
| Primary category | Insurance AI | Insurance AI |
| Founded | 2018 | Not published |
| Headquarters | Paris, France | London, United Kingdom |
| Website | www.akur8.com | www.hyperexponential.com |
Side by Side
Select any grade to read the note behind it.
| Axis | A Akur8 |
H hyperexponential |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model Risk Management and Transparency | ||
| Operational and Outcome Evidence | ||
| AI Safety and Data Stewardship | ||
| GLBA and Data Privacy Posture | ||
| Security Certifications and Trust Center | ||
| Regulatory Status and Licensure | ||
| AI Governance and Bias Disclosure | ||
| AI Liability and Recourse | ||
| Model Supply Chain Disclosure | ||
| Core Systems and Integration Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Institution and Segment Coverage |
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Akur8
-
Product / capability
Akur8 launched Akur8 Agents, starting with one agent for each module of its insurance pricing platform.
Source -
Integration / interoperability
Akur8 launched the Akur8 Deploy Rating Accelerator on the Guidewire Marketplace.
Source
The short version of each
Akur8
Akur8 is an actuarial platform for non life insurance pricing and reserving built on Transparent Machine Learning, automating feature engineering and risk model construction while keeping every variable contribution visible. A rate repository and deployment engine carry approved rates into production, and the Arius reserving product was acquired from Milliman. According to the AI FinTech Index, Akur8's models are validated outside the vendor: every model passes two external checks the vendor does not control, a certified actuary signing under professional obligation and a regulator receiving it as a rate filing. Its customer evidence is detailed, across roughly 330 customers in more than 40 countries including AXA, Generali, Munich Re and Tokio Marine. No provider or data boundary is named for the newer transparent agents and unstructured filing intelligence, no accuracy figure is published for the modeling engine, and nothing states whether one carrier's exposure data or model structures inform another's.
Source: AI FinTech Index, 2026
hyperexponential
hyperexponential builds a pricing decision intelligence platform for commercial property and casualty insurers, reinsurers and managing general agents. It replaces spreadsheet based rating with a Python engine in which the carrier's own actuaries author, deploy and version pricing models, with more than $45 billion of gross written premium contracted annually. An AI layer covers ingestion, a virtual actuarial assistant, Portfolio Intelligence and agentic Triage. According to the AI FinTech Index, hyperexponential documents its integrations in detail, with named partnerships, an explicit statement that the policy administration system remains the system of record, and a portability commitment giving customers structured access to all data, configuration and code, which this market rarely offers in writing. Its AI sits around a rating core that predates and survives the models. Oversight is asserted through the word governed with no threshold or sampling control named, no supplier is identified behind its foundation models, and there is no fairness account for appetite based triage trained on historical writing patterns.
Source: AI FinTech Index, 2026
Common questions
Is Akur8 better than hyperexponential for insurance pricing?
They divide on who builds the model. Akur8 constructs risk models automatically with every coefficient legible, and its models are validated outside the vendor, because a certified actuary signs each model and a regulator receives it as a rate filing. hyperexponential provides the engine in which the carrier's own actuaries write, deploy and version the models, and documents its integrations in detail, with named partners, a stated system of record boundary and a written portability commitment. If you want the model built, it is the first. If you want the tooling and to keep the intellectual property, it is the second. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
How are Akur8's models validated?
Externally, and the validation is mandatory rather than self declared. Every model the platform produces passes two checks the vendor does not control: a certified actuary signs it under professional obligation, and a regulator receives it as a rate filing with the power to reject it. Full transparency of every variable contribution, traceable workflows, a rate repository built for submission and automated documentation aimed at audit requirements support it. No accuracy figure for the modeling engine itself is published. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
How central is AI to hyperexponential?
It surrounds the rating core rather than performing the rating. Without the machine learning, hx Renew survives intact, because the pricing itself is performed by models the carrier's own actuaries write in Python and no model learns the price, so what the company is bought for, rating complex specialty risk, would continue to work. The AI line is real and shipped rather than a roadmap, covering a data ingestion library, a virtual actuarial assistant, Portfolio Intelligence and agentic Triage, but it sits at ingestion, triage and authoring assistance around a rating core that predates it. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
Are these two companies competitors?
Partly. They hold a partnership covering specialty and commercial pricing, and hyperexponential also partners with Cytora for risk digitization, so a carrier may encounter both inside one architecture rather than choosing between them. Where they do compete, the overlap is commercial and specialty pricing, and the choice is between a platform that builds the risk model for you and one that gives your actuaries the engine to build it themselves. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
What should diligence establish at both?
Neither discloses which models sit behind the newer agentic and ingestion layers, who supplies them, or whether submission content, loss runs or filings reach an external provider. Neither states the cross customer boundary, though your competitors price on the same platform. At hyperexponential, what the word governed means operationally is not published: no confidence threshold, escalation trigger, approval gate or sampling control on automated output is named. At Akur8, the audit and documentation artifacts its framework is described as producing are not public, and no approval gate is described for the transparent agents automating actuarial steps. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
Where does each publish the most, and the least?
Both document customer evidence in detail, with named carriers at the top of the market and published outcome figures. Akur8 publishes most on validation, through an actuary's signature and rate filings, and documents bias and fairness in part because constraint is a product feature rather than only visibility. It says little about the models and providers behind its newer agents. hyperexponential publishes most on integrations, carried by named partners and a written portability commitment, and says little about how central AI is, how customer data is kept apart and used, or bias and fairness. Graded by AI FinTech Index against the same capability axes from each vendor's own published materials, verified September 5, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Insurance AI page.
Neither says much about the models and providers it is built on, and in both cases the gap sits in the newer layer rather than the core. Akur8's modeling engine is proprietary and built in house with a named infrastructure provider, but the transparent agents automating actuarial steps and the market intelligence product reading unstructured regulatory filings both imply language models, and no provider, hosting arrangement or data boundary is named for either. hyperexponential describes its platform layer as foundation models, agent frameworks and inference governed for insurance, which names the class and identifies no supplier, model family, version or country of processing.
Its pricing models are fully known to the buyer because the carrier wrote them, so the exposure sits in ingestion, triage and the assistant, where a buyer cannot determine whether broker submission content, loss runs and financials reach an external provider.
Neither states the cross customer boundary, and it matters in this category because pricing and risk selection are precisely where carriers compete: competing insurers model their own books on one platform, and pricing models are the most closely held intellectual property a specialty carrier owns.
At hyperexponential the word governed is doing the work a mechanism should do, with no confidence threshold, escalation trigger, review queue or sampling control named, and its audit trail is a reconstruction capability after the fact rather than a control in the path. Neither publishes an accuracy figure for its own engine.